These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31316957)

  • 1. Making Hard Choices in Local Public Health Spending With a Cost-Benefit Analysis Approach.
    Robertson L; Skelly C; Phillips D
    Front Public Health; 2019; 7():147. PubMed ID: 31316957
    [No Abstract]   [Full Text] [Related]  

  • 2. Health economic analysis for the 'CURE Project' pilot: a hospital-based tobacco dependency treatment service in Greater Manchester.
    Evison M; Cox J; Howle F; Groom K; Moore R; Clegg H; Pearse C; Rutherford M; Tempowski A; Grundy S; Turnpenny B; Law H; Sundar R; Butt AT; Abdelaziz M; Coyne J; Crossfield A; O'Rourke C; Shackley D
    BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34949573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of drug treatment services: review of the literature*.
    Cartwright WS
    J Ment Health Policy Econ; 2000 Mar; 3(1):11-26. PubMed ID: 11967433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the cost-effectiveness of salt reformulation and increasing access to leisure centres in England, with PRIMEtime CE model validation using the AdViSHE tool.
    Briggs ADM; Wolstenholme J; Scarborough P
    BMC Health Serv Res; 2019 Jul; 19(1):489. PubMed ID: 31307459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing a Baseline: Community Benefit Spending by Not-for-Profit Hospitals Prior to Implementation of the Affordable Care Act.
    Leider JP; Tung GJ; Lindrooth RC; Johnson EK; Hardy R; Castrucci BC
    J Public Health Manag Pract; 2017; 23(6):e1-e9. PubMed ID: 27997478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social return on investment economic evaluation of supportive care for lung cancer patients in acute care settings in Australia.
    Hyatt A; Chung H; Aston R; Gough K; Krishnasamy M
    BMC Health Serv Res; 2022 Nov; 22(1):1399. PubMed ID: 36419150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Return on Investment of the Primary Health Care Integrated Geriatric Services Initiative Implementation.
    Thanh NX; Patil T; Knudsen C; Hamlin SN; Lightfoot H; Hanson HM; Cleaver D; Chan K; Silvius J; Oddie S; Fielding S
    J Ment Health Policy Econ; 2020 Sep; 23(3):101-109. PubMed ID: 32853159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from the evolution of 401(k) retirement plans for increased consumerism in health care: an application of behavioral research.
    DiCenzo J; Fronstin P
    EBRI Issue Brief; 2008 Aug; (320):1, 3-26. PubMed ID: 18724525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-Based Community Health Worker Program Addresses Unmet Social Needs And Generates Positive Return On Investment.
    Kangovi S; Mitra N; Grande D; Long JA; Asch DA
    Health Aff (Millwood); 2020 Feb; 39(2):207-213. PubMed ID: 32011942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using cost-benefit analysis and social return on investment to evaluate the impact of social enterprise: Promises, implementation, and limitations.
    Cordes JJ
    Eval Program Plann; 2017 Oct; 64():98-104. PubMed ID: 28011094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules.
    O'Brien BJ; Sculpher MJ
    Med Care; 2000 May; 38(5):460-8. PubMed ID: 10800973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing costs and potential returns of evidence-based programs for seniors.
    Miller TR; Dickerson JB; Smith ML; Ory MG
    Eval Health Prof; 2011 Jun; 34(2):201-25. PubMed ID: 21196430
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.